|
We are thrilled to share our newly published 2024 ECVAM Status Report!
The report highlights our progress in contributing to wider EU efforts to reduce and ultimately eliminate the use of animals in testing and research.
Some key takeaways:
✅ Biotechnology boom: Unprecedented growth in the biotech sector is driving innovation and transforming many domains including biomedical research, development of medicines and in vitro testing.
✅ Standards for in vitro biotech innovation: ECVAM’s work has been instrumental in driving standardisation efforts in the in vitro biotech sector, including contributing to a standardisation roadmap produced by the CEN-CENELEC Focus Group on Organ on Chip.
✅ Better protection of workers and consumers from mutagenic chemicals: ECVAM is leading an informal working group at the UN updating GHS classification criteria to improve the identification of mutagenic chemicals and make better use of non-animal hazard data.
✅ Roadmap to phase out animal testing: We are actively supporting the preparation of the Commission’s roadmap to accelerate the replacement of animal testing in chemical safety assessments.
Learn more by diving into the full report!
|
